StockData
Aurinia Pharmaceuticals Inc. logo

Aurinia Pharmaceuticals Inc. (AUPH) stock

AUPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 13/3058% below fair value
$15.13−0.27 (-1.75%)

Close on Nov 18, 2026Market cap $2.03BP/E 6.6Yield –

Aurinia Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2019 it was -$63.67M.

Annual free cash flow

PeriodPeriod endValueChange
FY2019Dec 31, 2019-$63.67M–
FY2018Dec 31, 2018-$51.64M–
FY2017Dec 31, 2017-$41.19M–
FY2016Dec 31, 2016-$18.73M–

More Aurinia Pharmaceuticals figures

See a number that looks wrong?